Your browser doesn't support javascript.
loading
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.
Boac, Bernadette M; Xiong, Yin; Marchion, Douglas C; Abbasi, Forough; Bush, Stephen H; Ramirez, Ingrid J; Khulpateea, Beman R; Clair McClung, E; Berry, Amy L; Bou Zgheib, Nadim; Chon, Hye Sook; Shahzad, Mian M; Judson, Patricia L; Wenham, Robert M; Apte, Sachin M; Berglund, Anders E; Magliocco, Anthony M; Lancaster, Johnathan M.
Afiliação
  • Boac BM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Xiong Y; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Marchion DC; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Electronic address: douglas.marchion@moffitt.org.
  • Abbasi F; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Bush SH; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Ramirez IJ; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Khulpateea BR; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Clair McClung E; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Berry AL; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Bou Zgheib N; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Chon HS; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Shahzad MM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Judson PL; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Re
  • Wenham RM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Re
  • Apte SM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Berglund AE; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Magliocco AM; Department of Women's Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Oncologic Sciences, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institut
  • Lancaster JM; Myriad Genetic Laboratories, Salt Lake City, UT 84108, USA.
Gynecol Oncol ; 140(2): 259-63, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26731723

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / MicroRNAs Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / MicroRNAs Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos